RCAR (RCAR) Stock Price & Analysis
RCAR (RCAR) rose 0.00% to USD 0 as of June 10, 2026 at 02:27 UTC, according to Nexqual real-time market data.
RCAR last closed at USD 0; the session ranged USD 0–0 on volume of 3,335 shares. Market capitalization is $8,735, with a 52-week range of USD 0–0 (PNK). Source: Nexqual, June 10, 2026 at 02:27 UTC.
Key Statistics (as of June 10, 2026 at 02:27 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0 |
| Day Range | USD 0 – 0 |
| 52-Week Range | USD 0 – 0 |
| Volume | 3,335 shares |
| Market Cap | $8,735 |
| Exchange | PNK |
Technical Analysis (RCAR)
Nexqual's technical model rates RCAR "STRONG SELL" based on 0 bullish and 5 bearish signals across 124 daily candles, as of June 10, 2026 at 02:27 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 100 (overbought) |
| vs SMA50 | Below (USD 0) |
| MACD | 0 (negative) |
Analyst Ratings (RCAR)
Wall Street analysts rate RCAR "None", per Nexqual as of June 10, 2026 at 02:27 UTC.
| Consensus Rating | None |
|---|
Earnings (RCAR)
Source: Nexqual, June 10, 2026 at 02:27 UTC.
Financials & Fundamentals (RCAR)
| Gross Margin | +0.00% |
|---|---|
| Operating Margin | +0.00% |
| Profit Margin | +0.00% |
| ROE | -568.90% |
| Current Ratio | 0.62 |
| Total Cash | $100,738 |
| Total Debt | $800,000 |
| Free Cash Flow | $-1.21M |
Source: Nexqual, June 10, 2026 at 02:27 UTC.
Financial Health Score (RCAR)
Nexqual rates RCAR's overall financial health "Weak" across five dimensions, as of June 10, 2026 at 02:27 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Weak — Gross margin 0%, operating 0% |
| Balance Sheet | Mixed — $101K cash, no debt |
| Cash Flow | Weak — Operating cash flow -$4M |
| Efficiency | Critical — ROE -569%, ROA -104.0% |
Ownership (RCAR)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 87.35M |
| Float | 22.46M |
Source: Nexqual, June 10, 2026 at 02:27 UTC.
Leadership (RCAR)
RCAR is led by Harmel S. Rayat (age 64), President, CEO, CFO & Interim Secretary, per Nexqual as of June 10, 2026 at 02:27 UTC.
| President, CEO, CFO & Interim Secretary | Harmel S. Rayat (age 64) |
|---|
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| WNDW | SolarWindow Technologies, Inc. | USD 0.28 | ▼ 16.67% |
| RGRX | REGENERX BIOPHARMACEUTICALS | USD 0 | ▲ 0% |
| EMMA | Emmaus Life Sciences, Inc. | USD 0.01 | ▼ 5.88% |
| RCEL | Avita Medical, Inc. | USD 4.12 | ▼ 1.44% |
| RVXCF | Resverlogix Corp. | USD 0.07 | ▼ 0.29% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 02:27 UTC. This page is informational and not investment advice.